60 Degrees Pharma Q1 Net Product Revenue Down 1% to $162K; Net Loss $2.21M

60 Degrees Pharmaceuticals, Inc. reported its financial results for the first quarter of fiscal year 2026, ending March 31, 2026. The company experienced a 1% decrease in net product revenues, falling to $162 thousand from $164 thousand in the prior year's quarter. Gross profit also declined to $76 thousand from $90 thousand, while operating expenses rose to $2.17 million. Consequently, the net loss attributable to common shareholders increased to $2.21 million, or $1.28 per share, compared to a net loss of $2.00 million, or $6.25 per share, in the first quarter of 2025.